Updated Guideline Recommendations for the Definitive Diagnosis of Unexplained Syncope.

Slides:



Advertisements
Similar presentations
Patients with suspected syncope should be investigated by cardiologists Dr NR Stout.
Advertisements

Syncope AM Report 6/25/10 Nicole Wilde. Syncope  Cause Not Obvious Neurally Mediated (vasovagal) 58% Cardiac Disease (arrhythmias) 23% Neurologic or.
Development of Clinical Pathways to Streamline Care for Patients Presenting with Suspected Cardiac Chest Pain Background The National Heart Foundation.
Obstructive Shock. Etiology of Shock Shock is identified according to its underlying cause. All types of shock progress through the same stages and exert.
Syncope diagnostic algorithm and management MUDr. Jakub Honěk Kardiologická klinika, 2.LF UK a FN Motol, Praha.
Copyright, 1996 © Dale Carnegie & Associates, Inc.
Code Sepsis: Current Evidence Based Guidelines and the CMS Sepsis Core Measure Adult Patients - Abbreviated Updated May 26, 2017.
Code Sepsis: Current Evidence Based Guidelines and the CMS Sepsis Core Measure Adult Patients - Abbreviated Updated August 30, 2017.
Multimodal Management of Opioid-Induced Constipation
What’s New in the 2013 ESC/ESH Hypertension Guideline
Disclaimer This presentation is intended only for use by Tulane University faculty, staff, and students. No copy or use of this presentation should occur.
Code Sepsis: Current Evidence Based Guidelines and the CMS Sepsis Core Measure Adult Patients - Abbreviated Updated August 30, 2017.
Multiple Organ Dysfunction Syndrome (MODS)
COPD.
Monitoring Continuum ISSUE-3 Atrial Fibrillation Classification.
ICD-10 and Clinical Documentation
New Guidelines to Prevent SCD: What You Need to Know
Update on the Diagnosis and Management of CTEPH in Latin America
Contemporary Diagnosis and Management of Unstable Angina
Cardiac Troponin.
Risk Stratification in PAH: What Do the Latest Data Suggest?
A Paradigm Shift in PAH.
Cardiogenic Shock.
The Clinical Enigma of Cardiogenic Shock
Preventing SCD With a WCD: Reviewing the Results of the VEST Trial
Challenges in the Diagnosis of MS: Physician and Nurse Perspectives
UNDERSTANDING RISK STRATIFICATION IN PAH:
The Patient Journey to Remission in MDD: A Collaborative Approach
Diagnostic Algorithms for ACS and High-Sensitivity Troponin
The Latest Data on Oral Prostacyclin Therapy in PAH
Case Challenges in Chronic Migraine
All About PAH:.
The Art and Science of Diagnosing Seizures
Heart Failure Prevention: Mission Impossible?
The Nurse View: Best Practices in Multiple Myeloma
Follow-Up of the Patient After PE
PAH in Adults CHEST Guideline and Expert Panel Report: Grading of Evidence
Case Collection in RA: Highlights of an Interactive Workshop
Checkpoint Inhibition
Program Goals. Treatment-Naive Patients With PAH What Do We Know and What Choices Do We Have?
Targeting Osteoporosis Therapies to Patients at Highest Risk for Fracture.
Rheumatoid Arthritis 2015 Guidelines What's New? What's Different?
Advancing Acute Coronary Syndrome Assessment:
Avoiding Opioid Overuse: Guideline-Based Management of Osteoarthritis
Examining the Latest Evidence in PAH
Translating the Latest and Greatest Advances in PAH Into Clinical Practice.
Primary Biliary Cholangitis
Tools to Address Adherence Issues in Patients With SIHD
Case Study 56-year-old Presents With 1 Year of Worsening Dyspnea
Oral Prostanoids and PAH
Preventing Clinical Events in PAH
Identifying High-Risk AF Patients
Cost-effective Approaches to Diagnosing Syncope
Case 1 Presentation Case 1 (cont) Assessment and Recommendations.
Managing HF in Primary Care
Breaking News in Pemphigus Vulgaris and the Latest Updates for Your Practice.
New ELN Recommendations
Iron Deficiency in Heart Failure
Pulmonary Hypertension Updates From 2018
The Rising Crisis of Prediabetes Diagnosis and Management of the Patient With Prediabetes.
Current Controversies and Advances in Hepatorenal Syndrome
Program Goals Background: Anticoagulation in Patients With VTE.
Hypovolemic Shock.
Perspective on the Multidisciplinary Management of PAH
Syncope diagnostic algorithm and management
High-Sensitivity Troponin in Clinical Practice
Diagnosing Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome
Merging the Art and Science of Managing nOH in Clinical Practice
My PAH Patient.
Shared Decision Making in MS
Presentation transcript:

Updated Guideline Recommendations for the Definitive Diagnosis of Unexplained Syncope

What Is Syncope?

Classification of Syncope

Pathophysiology of Syncope

Initial Evaluation and Risk Stratification of Patients With Syncope

Initial Evaluation: Syncopal Event

Initial Evaluation: Past Medical History

Initial Evaluation: Physical Examination

Initial Evaluation: Electrocardiogram

ED Syncope Risk Stratification

Cardiac Causes of Syncope Warranting Further Hospital Evaluation

Diagnostic Work-Up for Unclear Initial Evaluation

Implantable Loop Recorder Recommendations

Patient Scenario: When to Use ICD

When to Use ILR?

When to Use ILR? (cont)

When to Use ILR? (cont)

Studies That Led to Revised Guidelines

Studies That Led to Revised Guidelines (cont)

Studies That Led to Revised Guidelines (cont)

Diagnostic Criteria For Syncope-ILR

Cost-Effectiveness of ILR (PICTURE Registry)

TLOC-Suspected Syncope Algorithm

Patient Scenario

Patient Scenario (cont)

Conclusion

Abbreviations

Abbreviations (cont)

Abbreviations (cont)